Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FortySix Venture Capital ("46VC") is a U.S.-based venture capital manager specializing in launching tailored early-stage investment funds within robust networks. A significant part of its activity involves funding innovation in the healthcare/life science sector through dedicated vehicles like the PhyCap Fund. It does not itself develop therapeutics or own clinical programs but invests broadly across enabling technologies—including digital health—in partnership with universities and mission-driven organizations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FortySix Venture Capital.